RCM
NEO icon

Riverhead Capital Management’s NeoGenomics NEO Stock Holding History

Riverhead Capital Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$189K Buy
9,900
+1,600
+19% +$37.5K 0.01% 1159
2019
Q2 		$182K Hold
8,300
– – 0.01% 1186
2019
Q1 		$170K Buy
+8,300
New +$144K 0.01% 1194

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Riverhead Capital Management's NEO Position: Q3 2019 in Review

Riverhead Capital Management increased its NeoGenomics (NEO) stake by 19% in Q3 2019, buying an estimated $37.5K and bringing the position to 9,900 shares worth $189K. The position accounts for 0.01% of the portfolio, ranked #1159.

Riverhead Capital Management first reported a position in NEO in Q1 2019 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Riverhead Capital Management held 9,900 shares of NeoGenomics worth $189K as of Q3 2019.
  • Riverhead Capital Management bought 1,600 NeoGenomics shares in Q3 2019, an estimated $37.5K.
  • NeoGenomics made up 0.01% of Riverhead Capital Management's portfolio in Q3 2019, its #1159 holding.
  • Riverhead Capital Management first reported a position in NeoGenomics in Q1 2019 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.